Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

US 6893869

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 17, 2005 · Expires May 12, 2025

US 6875433

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Apr 5, 2005 · Expires Mar 31, 2025

US 6872398

Conjugate vaccine against gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Mar 29, 2005 · Expires Mar 24, 2025

US 6869602

Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells

The United States of America as represented by the Secretary of the Army · Granted Mar 22, 2005 · Expires Mar 17, 2025

US 6869787

Ricin vaccine and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Mar 22, 2005 · Expires Mar 17, 2025

US 6869604

Recombinant anti-tumor RNAse

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 22, 2005 · Expires Mar 17, 2025

US 6855322

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Feb 15, 2005 · Expires Feb 10, 2025

US 6855331

Sustained release hydrophobic bioactive PLGA microspheres

The United States of America as represented by the Secretary of the Army · Granted Feb 15, 2005 · Expires Feb 10, 2025

US 6852842

Methods for functional kidney imaging using small dendrimer contrast agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 8, 2005 · Expires Feb 3, 2025

US 6844010

Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

The United States of America as represented by the Secretary of the Army · Granted Jan 18, 2005 · Expires Jan 13, 2025

US 6833132

Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 21, 2004 · Expires Dec 16, 2024

US 6828309

Use of pentosan polysulfate to treat certain conditions of the prostate

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 7, 2004 · Expires Dec 2, 2024

US 6825323

Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same

The United States of America as represented by the Secretary of the Army · Granted Nov 30, 2004 · Expires Nov 25, 2024

US 6815425

Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same

The United States of America as represented by the Secretary of the Army · Granted Nov 9, 2004 · Expires Nov 4, 2024

US 6809184

Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 26, 2004 · Expires Oct 21, 2024

US 6797276

Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response

The United States of America as represented by the Secretary of the Army · Granted Sep 28, 2004 · Expires Sep 23, 2024

US 6793927

Construction of Pasteurella haemolytica vaccines

The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6787145

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 7, 2004 · Expires Sep 2, 2024

US 6770479

Anthrax vaccine

The United States of America as represented by the Secretary of the Army · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6756201

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1

The United States of America as represented by the Department of Health and Services · Granted Jun 29, 2004 · Expires Jun 24, 2024

US 6730498

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted May 4, 2004 · Expires Apr 29, 2024

US 6716450

Enhancing protein activity through nanoencapsulation

The United States of America as represented by the Secretary of the Army · Granted Apr 6, 2004 · Expires Apr 1, 2024

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

The United States of America as represented by the Secretary of the Army · Granted Mar 30, 2004 · Expires Mar 25, 2024